demonstrated using both mouse models and human samples that dysregulation of lipid metabolism in nonalcoholic fatty liver disease leads to the selective depletion of activated CD4+ T cells within the liver, which accelerates hepatocarcinogenesis. Here, CD4 is linked to metabolic dysfunction-associated steatotic liver disease.